胆道癌治疗中新兴的 claudin-18.2 拮抗剂
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer.
靶向 CLDN-18.2 是治疗实体瘤(包括 BTC)的一种有前景的新方法。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
把在研试验和前沿论文合在一起看,按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和(导航里的「临床试验」板块只收在招的那部分,不另计入)。
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer.
靶向 CLDN-18.2 是治疗实体瘤(包括 BTC)的一种有前景的新方法。
FNDC4 Drives Metastasis and Immune Evasion in Pancreatic Cancer.
Innovative CAR-T approaches targeting Claudin 18.2 to counteract drug resistance in gastric cancer.
Claudin18.2 as a Promising Therapeutic Target in Gastric Cancer.
Brave new world-new and emerging treatments for gastric cancer.
Emerging targets in gastroesophageal adenocarcinoma: what the future looks like.
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies.
共 7 条
MEMBER ACCOUNT
登录成功会直接打开下一页。